13D Filing: Farallon Capital and Nexvet Biopharma PLC (NVET)

Page 66 of 68

Page 66 of 68 – SEC Filing

SCHEDULE
Convertible Securities details
5,100 Restricted Share Units

Follow Nexvet Biopharma Plc (NASDAQ:NVET)

Page 66 of 68